Hindustan Bio Sciences Reports Stable Q3 FY24-25 Results with Strong Debtors Turnover Ratio

Jan 30 2025 06:46 PM IST
share
Share Via
Hindustan Bio Sciences has announced its financial results for Q3 FY24-25, showcasing stable performance and significant operational metrics. The Debtors Turnover Ratio reached 22.40 times, marking the highest turnover rate in recent periods, indicating effective management of receivables and debt settlement.
Hindustan Bio Sciences, a microcap player in the Pharmaceuticals & Drugs industry, has recently reported its financial results for the quarter ending December 2024. The results indicate a stable financial performance for Q3 FY24-25, with notable developments in the company's operational metrics.

One significant highlight is the Debtors Turnover Ratio, which has reached a remarkable 22.40 times on a half-yearly basis. This figure represents the highest turnover rate recorded over the last five half-year periods, suggesting that the company has been effective in managing its receivables and settling debts more swiftly.

In terms of evaluation changes, Hindustan Bio Sciences has experienced a revision in its score, moving from 0 to 2 over the past three months. This adjustment reflects a shift in assessment, indicating a more favorable view of the company's recent performance metrics.

As the company continues to navigate the competitive landscape of the pharmaceuticals sector, these developments may play a crucial role in shaping its operational strategies moving forward.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Hind.Bio Science falling/rising?
Nov 29 2025 12:44 AM IST
share
Share Via
Why is Hind.Bio Science falling/rising?
Nov 18 2025 10:20 PM IST
share
Share Via
Is Hind.Bio Science overvalued or undervalued?
Nov 04 2025 08:06 AM IST
share
Share Via
Why is Hind.Bio Science falling/rising?
Oct 30 2025 10:08 PM IST
share
Share Via
Why is Hind.Bio Science falling/rising?
Oct 24 2025 10:20 PM IST
share
Share Via
Why is Hind.Bio Science falling/rising?
Oct 23 2025 10:05 PM IST
share
Share Via